Search Within

Immunology Program Faculty

  1. "Jedd Wolchok"
Formats
  1. Journal Article (73)
  2. Meeting Abstract (49)
  3. Book Section (6)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (131)
  2. GSK Faculty (131)
  3. Melanoma and Immunotherapeutics Service (131)
  4. Sloan Kettering Institute Faculty (131)
  5. Solid Tumor Oncology Division (131)
  6. Hematologic Malignancies, Division of (54)

More Groups

People
  1. Jedd Wolchok (131)
  2. Alan Houghton (118)
  3. Taha Merghoub (37)
  4. Miguel-Angel Perales (32)
  5. Cailian Liu (17)
  6. Daniel Hirschhorn Cymerman (17)

More People

Years
  1. 2022 (4)
  2. 2021 (2)
  3. 2020 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2016 (2)

More Years

Publications
  1. Cancer Research (13)
  2. Blood (9)
  3. Clinical Cancer Research (8)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (7)
  5. Cancer Immunity (6)
  6. Journal of Immunology (6)

More Publications

Publishers
  1. American Association for Cancer Research (30)
  2. Elsevier Inc. (11)
  3. American Society of Hematology (9)
  4. Nature Publishing Group (9)
  5. Academy of Cancer Immunology (6)
  6. The American Association of Immunologists, Inc (6)

More Publishers

Results (131)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Combination of cyclophosphamide with immune checkpoint blockade inhibition elicits potent tumor control in a preclinical melanoma model
    Meeting Abstract

    George, M. M.; Warner, A. B.; Hamadene, L.; Hirschhorn, D.; Houghton, A. N.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reprogramming the tumor microenvironment by a second-generation recombinant modified vaccinia virus Ankara
    Meeting Abstract

    Liu, S.; Mazo, G.; Yang, N.; Zhang, T.; Tariq, S. B.; Wang, Y.; Hirschhorn-Cymerman, D.; Ji, L.; Tan, A.; Wang, J.; more...
    Journal of Investigative Dermatology (2022)

    Fulltext@MSK | Save
  • T-VEC treatment reverses PD-1 resistance by altering the microenvironment of tumors
    Meeting Abstract

    Theriot, J.; Hu, J.; Wong, R. J.; Wolchok, J.; Rudensky, A.; Ariyan, C.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
    Journal Article

    Hirschhorn, D.; Betof Warner, A.; Maniyar, R.; Chow, A.; Mangarin, L. M. B.; Cohen, A. D.; Hamadene, L.; Rizzuto, G. A.; Budhu, S.; Suek, N.; more...
    JCI Insight (2021)

    Fulltext@MSK | Save
  • Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
    Journal Article

    Ogishi, M.; Yang, R.; Aytekin, C.; Langlais, D.; Bourgey, M.; Khan, T.; Al Ali, F.; Rahman, M.; Delmonte, O. M.; Chrabieh, M.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • Immigration in science
    Editorial

    Casanova, J. L.; Holtzman, D. M.; Kaech, S. M.; Lanier, L. L.; Nathan, C. F.; Rudensky, A. Y.; Tuveson, D.; Wolchok, J. D.
    Journal of Experimental Medicine (2020)

    Fulltext@MSK | Save
  • Determinants of COVID-19 disease severity in patients with cancer
    Research Letter

    Robilotti, E. V.; Babady, N. E.; Mead, P. A.; Rolling, T.; Perez-Johnston, R.; Bernardes, M.; Bogler, Y.; Caldararo, M.; Figueroa, C. J.; Glickman, M. S.; more...
    Nature Medicine (2020)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Blockade of surface-bound TGF-ß on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
    Journal Article

    Budhu, S.; Schaer, D. A.; Li, Y.; Toledo-Crow, R.; Panageas, K.; Yang, X.; Zhong, H.; Houghton, A. N.; Silverstein, S. C.; Merghoub, T.; more...
    Science Signaling (2017)

    Fulltext@MSK | Save